Swiss Entertainment Update
SEE OTHER BRANDS

Exploring the arts and entertainment news of Switzerland

Swiss Entertainment Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Swiss Entertainment Update.

Press releases published on June 19, 2025

Brenus Pharma and InSphero have developed 3D tumor spheroids mimicking in vivo human colorectal cancer conditions

Brenus Pharma and InSphero have developed 3D tumor spheroids mimicking in vivo human colorectal cancer conditions

PPromising results show the impact of Brenus Pharma and InSphero’s collaboration in advancing translational immunotherapy through scalable 3D tumor models. SCHLIEREN, ZURICH, SWITZERLAND, June 19, 2025 /⁨EINPresswire.com⁩/ -- Brenus Pharma, a French …

XS.com est couronné "Courtier le Plus Innovant" aux UF Awards - Global 2025

XS.com est couronné "Courtier le Plus Innovant" aux UF Awards - Global 2025

SWITZERLAND, June 19, 2025 /⁨Business News⁩/ -- XS.com, leader mondial dans le domaine de la FinTech et du trading en ligne, a reçu le prestigieux titre de "Courtier le Plus Innovant" lors de la cérémonie mondiale des UF Awards, qui s'est tenue à l' …

Superlab Suisse to Open New Facility at Campus Biotech in Geneva in January 2026

Superlab Suisse to Open New Facility at Campus Biotech in Geneva in January 2026

Zurich, June 19, 2025 (GLOBE NEWSWIRE) -- Superlab Suisse has announced the opening of its fourth Swiss laboratory facility at Campus Biotech in Geneva, which will be ready for move-in by January 2026. The new location will offer fully serviced laboratory …

Official Launch of 9S UNION – The Global Economic Alliance at GIFPP Forum

Official Launch of 9S UNION – The Global Economic Alliance at GIFPP Forum

ZURICH, June 19, 2025 (GLOBE NEWSWIRE) -- The Global Investment Forum for Peace …

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update

Strong cash position of CHF2.8 million at end of Q1 2025 GABAB PAM chronic cough candidate demonstrated robust anti-tussive activity in disease models Regained rights to our phase 2 mGlu2 PAM asset, ADX71149 Indivior advanced GABAB PAM Substance use …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service